Skip to main content

Upcoming holiday closures 

Quest Patient Service Centers will be closed on Friday, July 3 and Saturday, July 4, 2026, in observance of Independence Day, and to give our frontline team the time to recharge. Don't let the holiday interrupt your care. Plan your visit today.

Hide
Quest Diagnostics

Clinical and Biochemical Footprints of Inherited Metabolic Disorders. XI. Gastrointestinal Symptoms

Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms

Authors: Salazar D, Kloke KM, Guerrero RB, Ferreira CR, Blau N

Citation: Mol Genet Metab. 2023 Feb 1;138(3):107528. doi: 10.1016/j.ymgme.2023.107528. Online ahead of print.

Specialties: Cardiovascular Disease, Endocrinology, Genetics, Neurology
 

Related content

Publication
Viral Pathogen Detection Using Multiplex Gastrointestinal Molecular Panels: The Pros and Cons of Viral Target Inclusion
Publication
Prognostic Implications of the Immune Tumor Microenvironment in Patients With Pancreatic and Gastrointestinal Neuroendocrine Tumors

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.